O-Glutarylpsilocin (developmental code name RE109), also known as 4-glutaryloxy-N,N-dimethyltryptamine (4-HO-DMT O-glutarate or 4-GO-DMT) is a serotonergic psychedelic of the tryptamine family. It acts as a prodrug of psilocin (4-HO-DMT) similarly to other psilocin prodrugs like 4-AcO-DMT, 4-PrO-DMT, and psilocybin (4-PO-DMT). The drug is cleaved into psilocin by non-specific esterases. O-Glutarylpsilocin was first described in the scientific literature in 2024. It has been patented by Reunion Neuroscience. A related drug, luvesilocin (RE-104, FT-104; 4-GO-DiPT), a prodrug of 4-HO-DiPT, is being developed for potential medical use.
Use and effects
Interactions
See also Substituted tryptamine List of investigational hallucinogens and entactogens CT-4201 EB-002 MSP-1014
References
External links DMT-4-glutarate - Isomer Design